Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
The Institute for Basic Science currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 pending office actions are distributed across 4 distinct art units, showing a high level of technical diversity relative to the number of active cases. This distribution suggests that the institute's research covers several distinct biological or pharmaceutical disciplines. The 4 pending office actions represent the entirety of the company's current active engagement with the patent office in this sector.
The prosecution is handled by 4 distinct examiners, with each examiner responsible for exactly one case. STOCKDALE, JESSICA NICOLE is the busiest examiner, holding 1 busiest examiner pending action. Because there are 4 distinct examiners for the 4 pending office actions, the institute's success in the Biotechnology & Pharmaceuticals sector depends on four independent review processes. This decentralized approach across 4 distinct art units ensures that the institute receives feedback from multiple technical perspectives, though it requires managing the specific requirements of 4 distinct examiners including STOCKDALE, JESSICA NICOLE.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOCKDALE, JESSICA NICOLE | 1 | 50.0% | +35.2% |
| LANIER, BENJAMIN E | 1 | 69.4% | +16.9% |
| BAKKAR, AYA ZIAD | 1 | 63.3% | +43.2% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 46.9% | +59.0% |
| MCCLAIN, STARFARI TESHAWN | 1 | 90.6% | -12.6% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 56.3% | +40.2% |
| ANDERSON-FEARS, KEENAN NEIL | 1 | 12.0% | +41.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18110028 | PHOTOCATALYST-ATTACHED FILTER AND PREPARING METHOD OF THE SAME | MCCLAIN, STARFARI TESHAWN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025446 | TARGETED DEAMINASE AND BASE EDITING USING SAME | LIPPOLIS, ALEXANDRA ROSE | 87d overdue |
| 18027023 | Methods and Systems for Modifying Empathy by Modulating Type 2 Theta Oscillations | BAKKAR, AYA ZIAD | — |
| 17614795 | METHOD FOR INHIBITING INFECTION AND ACTIVATION OF VIRUS | DACE DENITO, ALEXANDRA GERALDINE | — |
| 17473253 | BRAIN CONNECTIVITY MARKER OF SUSTAINED PAIN AND METHOD OF DIAGNOSING SUSTAINED PAIN USING THE SAME | ANDERSON-FEARS, KEENAN NEIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025446 | TARGETED DEAMINASE AND BASE EDITING USING SAME | LIPPOLIS, ALEXANDRA ROSE | 87d overdue |
| 18131347 | QUANTUM-RESISTANT CRYPTOSYSTEM AND ELECTRONIC DEVICE INCLUDED IN THE SAME | LANIER, BENJAMIN E | 12d |
| 19113550 | BASE EDITING OF PLANT CELL ORGANELLE DNA | STOCKDALE, JESSICA NICOLE | — |
| 18027023 | Methods and Systems for Modifying Empathy by Modulating Type 2 Theta Oscillations | BAKKAR, AYA ZIAD | — |
| 17614795 | METHOD FOR INHIBITING INFECTION AND ACTIVATION OF VIRUS | DACE DENITO, ALEXANDRA GERALDINE | — |
| 17473253 | BRAIN CONNECTIVITY MARKER OF SUSTAINED PAIN AND METHOD OF DIAGNOSING SUSTAINED PAIN USING THE SAME | ANDERSON-FEARS, KEENAN NEIL | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| 2437 | 1 |
| 3796 | 1 |
| 1637 | 1 |
| 1736 | 1 |
| 1636 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19113550 | BASE EDITING OF PLANT CELL ORGANELLE DNA | STOCKDALE, JESSICA NICOLE | 1663 | §102§103§112DP | Non-Final OA | — | Pending | Mar 20, 2025 |
| 18131347 | QUANTUM-RESISTANT CRYPTOSYSTEM AND ELECTRONIC DEVICE INCLUDED IN THE SAME | LANIER, BENJAMIN E | 2437 | §103 | Final Rejection | 12d | Pending | Apr 05, 2023 |
| 18027023 | Methods and Systems for Modifying Empathy by Modulating Type 2 Theta Oscillations | BAKKAR, AYA ZIAD | 3796 | §103§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 18025446 | TARGETED DEAMINASE AND BASE EDITING USING SAME | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103§112 | Final Rejection | 87d overdue | Pending | Mar 09, 2023 |
| 18110028 | PHOTOCATALYST-ATTACHED FILTER AND PREPARING METHOD OF THE SAME | MCCLAIN, STARFARI TESHAWN | 1736 | §103 | Final Rejection | — | Pending | Feb 15, 2023 |
| 17614795 | METHOD FOR INHIBITING INFECTION AND ACTIVATION OF VIRUS | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §102§103§112 | Non-Final OA | — | Pending | Nov 29, 2021 |
| 17473253 | BRAIN CONNECTIVITY MARKER OF SUSTAINED PAIN AND METHOD OF DIAGNOSING SUSTAINED PAIN USING THE SAME | ANDERSON-FEARS, KEENAN NEIL | 1687 | §103§112 | Final Rejection | — | Pending | Sep 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial